Natural Disease Progression in Participants With Choroideremia

CompletedOBSERVATIONAL
Enrollment

1,178

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

May 7, 2021

Study Completion Date

August 10, 2021

Conditions
Choroideremia
Interventions
OTHER

No Intervention

Administered as specified in the treatment arm.

Trial Locations (1)

94107

Research Site, San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Biogen

INDUSTRY

NCT04795206 - Natural Disease Progression in Participants With Choroideremia | Biotech Hunter | Biotech Hunter